Azithramycine

Azithramycine is a lipid of Polyketides (PK) class. Azithramycine is associated with abnormalities such as Respiratory Tract Infections, Pneumonia, Lower respiratory tract infection, Infection and Nonspecific urethritis. The involved functions are known as Lysis, Selection, Genetic, Mutation, Relapse and Adaptation. Azithramycine often locates in Blood, Respiratory System, Genitourinary system, Back and Chest. The associated genes with Azithramycine are Genes, rRNA, Genome, RPL22 gene, OPRM1 gene and tryptic soy broth. The related lipids are Liposomes, Phosphatidylserines, Promega, Lipopolysaccharides and Steroids. The related experimental models are Mouse Model, Knock-out and Tissue Model.

Cross Reference

Introduction

To understand associated biological information of Azithramycine, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Azithramycine?

Azithramycine is suspected in Infection, Pneumonia, Trachoma, Respiratory Tract Infections, Gonorrhea, Infectious disease of lung and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Azithramycine

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Airway Obstruction D000402 13 associated lipids
Stomach Ulcer D013276 75 associated lipids
Diarrhea D003967 32 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Hearing Loss, Sensorineural D006319 8 associated lipids
Otitis Media D010033 12 associated lipids
Carcinoma, Basal Cell D002280 6 associated lipids
Bacterial Infections D001424 21 associated lipids
Pain D010146 64 associated lipids
Stomach Diseases D013272 7 associated lipids
Genital Diseases, Female D005831 7 associated lipids
Lung Diseases D008171 37 associated lipids
Sarcoidosis D012507 13 associated lipids
Hyperglycemia D006943 21 associated lipids
Carcinoma, Squamous Cell D002294 14 associated lipids
Skin Neoplasms D012878 12 associated lipids
Burns D002056 34 associated lipids
Inflammation D007249 119 associated lipids
Colitis D003092 69 associated lipids
Per page 10 20 50 100 | Total 276

PubChem Associated disorders and diseases

What pathways are associated with Azithramycine

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Azithramycine?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Azithramycine?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Azithramycine?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Azithramycine?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Azithramycine?

Mouse Model

Mouse Model are used in the study 'Azithromycin increases in vitro fibronectin production through interactions between macrophages and fibroblasts stimulated with Pseudomonas aeruginosa.' (Cory TJ et al., 2013), Mouse Model are used in the study 'Efficacy of azithromycin, clarithromycin and beta-lactam agents against experimentally induced bronchopneumonia caused by Haemophilus influenzae in mice.' (Miyazaki S et al., 2001), Mouse Model are used in the study 'Oral anti-pneumococcal activity and pharmacokinetic profiling of a novel peptide deformylase inhibitor.' (Gross M et al., 2004), Mouse Model are used in the study 'Inhibition of quorum sensing in Pseudomonas aeruginosa by azithromycin and its effectiveness in urinary tract infections.' (Bala A et al., 2011) and Mouse Model are used in the study 'Enhanced efficacy of single-dose versus multi-dose azithromycin regimens in preclinical infection models.' (Girard D et al., 2005).

Knock-out

Knock-out are used in the study 'Influence of rhlR and lasR on Polymyxin Pharmacodynamics in Pseudomonas aeruginosa and Implications for Quorum Sensing Inhibition with Azithromycin.' (Bulman ZP et al., 2017) and Knock-out are used in the study 'Azithromycin in Pseudomonas aeruginosa biofilms: bactericidal activity and selection of nfxB mutants.' (Mulet X et al., 2009).

Tissue Model

Tissue Model are used in the study 'Development of a population pharmacokinetic model characterizing the tissue distribution of azithromycin in healthy subjects.' (Zheng S et al., 2014).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Azithramycine

Download all related citations
Per page 10 20 50 100 | Total 4404
Authors Title Published Journal PubMed Link
[Antibiotics in routine practice. With proper selection rapid success]. 2002 MMW Fortschr Med pmid:12532526
[Azithromycin for pediatric indications. Brief therapy is ideal for children]. 2002 MMW Fortschr Med pmid:12532527
Dakdouki GK et al. Azithromycin-induced rash in infectious mononucleosis. 2002 Scand. J. Infect. Dis. pmid:12587634
Esteban J et al. A comparison between disk diffusion and microdilution for susceptibility testing of Mycobacterium fortuitum complex. 2002 J Chemother pmid:12583544
Hauke W et al. Esberitox N as supportive therapy when providing standard antibiotic treatment in subjects with a severe bacterial infection (acute exacerbation of chronic bronchitis). A multicentric, prospective, double-blind, placebo-controlled study. 2002 Chemotherapy pmid:12476043
Kamau FN et al. Isocratic liquid chromatographic method for the analysis of azithromycin and its structurally related substances in bulk samples. 2002 J Chromatogr Sci pmid:12433117
Tyteca D et al. Azithromycin, a lysosomotropic antibiotic, has distinct effects on fluid-phase and receptor-mediated endocytosis, but does not impair phagocytosis in J774 macrophages. 2002 Exp. Cell Res. pmid:12441132
Aguirrebengoa K et al. [Endocarditis due to Bartonella henselae on a native valve. A new case with some notable aspects]. 2002 Enferm. Infecc. Microbiol. Clin. pmid:12372243
Ivashkin VT et al. Azithromycin in a triple therapy for H.pylori eradication in active duodenal ulcer. 2002 World J. Gastroenterol. pmid:12378634
Hook EW et al. A randomized, comparative pilot study of azithromycin versus benzathine penicillin G for treatment of early syphilis. 2002 Sex Transm Dis pmid:12172535
Ohrt C et al. Assessment of azithromycin in combination with other antimalarial drugs against Plasmodium falciparum in vitro. 2002 Antimicrob. Agents Chemother. pmid:12121927
Gandhi R et al. Characterization of azithromycin hydrates. 2002 Eur J Pharm Sci pmid:12128172
Khan WA et al. Comparison of single-dose azithromycin and 12-dose, 3-day erythromycin for childhood cholera: a randomised, double-blind trial. 2002 Lancet pmid:12480424
Pastor E et al. [Macrolide consumption according to geographic areas in the province of Valladolid]. 2002 Enferm. Infecc. Microbiol. Clin. pmid:12433351
Yee CL et al. Tendon or joint disorders in children after treatment with fluoroquinolones or azithromycin. 2002 Pediatr. Infect. Dis. J. pmid:12182376
Clark C et al. In vitro selection of resistance in Haemophilus influenzae by amoxicillin-clavulanate, cefpodoxime, cefprozil, azithromycin, and clarithromycin. 2002 Antimicrob. Agents Chemother. pmid:12183253
Blandizzi C et al. Distribution of azithromycin in plasma and tonsil tissue after repeated oral administration of 10 or 20 milligrams per kilogram in pediatric patients. 2002 Antimicrob. Agents Chemother. pmid:11959610
Ekici A et al. Effect of azithromycin on the severity of bronchial hyperresponsiveness in patients with mild asthma. 2002 J Asthma pmid:11990233
Mohler AM Treatment of streptococcal pharyngitis. 2002 Am Fam Physician pmid:11996411
Davis JL et al. Pharmacokinetics of azithromycin in foals after i.v. and oral dose and disposition into phagocytes. 2002 J. Vet. Pharmacol. Ther. pmid:12000529
Mandell GL and Coleman EJ Effect of antipyretic agents on uptake, transport, and release of antimicrobial agents by human polymorphonuclear leukocytes. 2002 J. Infect. Dis. pmid:12001049
Treadway G et al. The safety of azithromycin in the treatment of adults with community-acquired respiratory tract infections. 2002 Int. J. Antimicrob. Agents pmid:11932140
[Unfortunately without effectiveness: chlamydia eradication after infarct]. 2002 MMW Fortschr Med pmid:12014269
Suriawinata A and Min AD A 33-year-old woman with jaundice after azithromycin use. 2002 Semin. Liver Dis. pmid:12016551
Evans AT et al. Azithromycin for acute bronchitis: a randomised, double-blind, controlled trial. 2002 Lancet pmid:12020525
Kutlin A et al. Effect of gemifloxacin on viability of Chlamydia pneumoniae (Chlamydophila pneumoniae) in an in vitro continuous infection model. 2002 J. Antimicrob. Chemother. pmid:12003969
Rustomjee R et al. A randomized controlled trial of azithromycin versus doxycycline/ciprofloxacin for the syndromic management of sexually transmitted infections in a resource-poor setting. 2002 J. Antimicrob. Chemother. pmid:12003988
Voytilla KL et al. Visual compatibility of azithromycin with 24 commonly used drugs during simulated Y-site delivery. 2002 Am J Health Syst Pharm pmid:12004465
Amsden GW et al. A study of the interaction potential of azithromycin and clarithromycin with atorvastatin in healthy volunteers. 2002 J Clin Pharmacol pmid:11936570
Lacroix JS et al. Symptoms and clinical and radiological signs predicting the presence of pathogenic bacteria in acute rhinosinusitis. 2002 Acta Otolaryngol. pmid:11936912
Ghaffar F et al. Effects of large dosages of amoxicillin/clavulanate or azithromycin on nasopharyngeal carriage of Streptococcus pneumoniae, Haemophilus influenzae, nonpneumococcal alpha-hemolytic streptococci, and Staphylococcus aureus in children with acute otitis media. 2002 Clin. Infect. Dis. pmid:11981724
Chimura T [Changes of antibody titers during antimicrobial therapy including levofloxacin for Chlamydia infections in the obstetrics and gynecology field]. 2002 Jpn J Antibiot pmid:12071097
Reshetniak VI et al. [Eradication of Helicobacter pylori in patients with duodenal ulcer following the short course of treatment with azitromycin and amoxycillin]. 2002 Antibiot. Khimioter. pmid:12087718
Kays MB et al. Azithromycin treatment failure in community-acquired pneumonia caused by Streptococcus pneumoniae resistant to macrolides by a 23S rRNA mutation. 2002 Diagn. Microbiol. Infect. Dis. pmid:12088625
Breier AR et al. Microbiological assay for azithromycin in pharmaceutical formulations. 2002 J Pharm Biomed Anal pmid:12093530
Muirhead GJ et al. The effects of steady-state erythromycin and azithromycin on the pharmacokinetics of sildenafil in healthy volunteers. 2002 Br J Clin Pharmacol pmid:11879258
Gomberg MA [Combined treatment of persisting urogenital chlamydia infection with sumamed and interferon alfa]. 2002 Antibiot. Khimioter. pmid:12365322
Hammerschlag MR Effect of azithromycin on endothelial function of patients with coronary artery disease and evidence of Chlamydia pneumoniae infection. 2002 Circulation pmid:12370232
Adimora AA Treatment of uncomplicated genital Chlamydia trachomatis infections in adults. 2002 Clin. Infect. Dis. pmid:12353204
Augenbraun MH Treatment of syphilis 2001: nonpregnant adults. 2002 Clin. Infect. Dis. pmid:12353205
Itoh M et al. [A case of immotile-dyskinetic cilia syndrome responding to clenbuterol hydrochloride and azithromycin]. 2002 Nihon Kokyuki Gakkai Zasshi pmid:12382429
Equi A et al. Long term azithromycin in children with cystic fibrosis: a randomised, placebo-controlled crossover trial. 2002 Lancet pmid:12383667
Ohara T et al. Effects of azithromycin on shiga toxin production by Escherichia coli and subsequent host inflammatory response. 2002 Antimicrob. Agents Chemother. pmid:12384353
Sullivan B et al. Comparison of azithromycin and clarithromycin in triple therapy regimens for the eradication of Helicobacter pylori. 2002 Am. J. Gastroenterol. pmid:12385435
Brook I Antibacterial therapy for acute group a streptococcal pharyngotonsillitis: short-course versus traditional 10-day oral regimens. 2002 Paediatr Drugs pmid:12390046
Tambiah J and Powell JT Chlamydia pneumoniae antigens facilitate experimental aortic dilatation: prevention with azithromycin. 2002 J. Vasc. Surg. pmid:12422113
Arnez M et al. Solitary erythema migrans in children: comparison of treatment with azithromycin and phenoxymethylpenicillin. 2002 Wien. Klin. Wochenschr. pmid:12422590
Maraspin V et al. Development of erythema migrans in spite of treatment with antibiotics after a tick bite. 2002 Wien. Klin. Wochenschr. pmid:12422612
Chandrupatla S et al. Azithromycin-induced intrahepatic cholestasis. 2002 Dig. Dis. Sci. pmid:12395890
Nagai K et al. Susceptibility to telithromycin in 1,011 Streptococcus pyogenes isolates from 10 central and Eastern European countries. 2002 Antimicrob. Agents Chemother. pmid:11796375
Zhou F et al. High accuracy mass measurement of peptides with internal calibration using a dual electrospray ionization sprayer system for protein identification. 2002 Rapid Commun. Mass Spectrom. pmid:11870887
Krudsood S et al. A comparative clinical trial of combinations of dihydroartemisinin plus azithromycin and dihydroartemisinin plus mefloquine for treatment of multidrug resistant falciparum malaria. 2002 Southeast Asian J. Trop. Med. Public Health pmid:12693587
Burton MJ et al. Azithromycin for the treatment and control of trachoma. 2002 Expert Opin Pharmacother pmid:11829725
Ohara T et al. [Protective effect of azithromycin against verotoxin]. 2002 Kansenshogaku Zasshi pmid:11905000
Salaria M and Singh M Atypical pneumonia in children. 2002 Indian Pediatr pmid:11910135
Desta Z et al. In vitro inhibition of pimozide N-dealkylation by selective serotonin reuptake inhibitors and azithromycin. 2002 J Clin Psychopharmacol pmid:11910261
Ito N and Kudo S [Case of polycystic lung disease with mixed infections due to Aspergillus and Mycobacterium fortuitum successfully treated by AZM]. 2002 Jpn J Antibiot pmid:12664928
Smith SR et al. A double-blind placebo-controlled trial of azithromycin as an adjunct to non-surgical treatment of periodontitis in adults: clinical results. 2002 J. Clin. Periodontol. pmid:11846850
Wu ML et al. Enterocolonic Mycobacterium avium-intracellulare. 2002 Arch. Pathol. Lab. Med. pmid:11860323
Cascio A and Colomba C [Macrolides in the treatment of children with Mediterranean spotted fever]. 2002 Infez Med pmid:12704264
Parchure N et al. Effect of azithromycin treatment on endothelial function in patients with coronary artery disease and evidence of Chlamydia pneumoniae infection. 2002 Circulation pmid:11901039
SoRelle R Treatment with azithromycin improves endothelial function. 2002 Circulation pmid:11902195
Kutlin A et al. Effect of prolonged treatment with azithromycin, clarithromycin, or levofloxacin on Chlamydia pneumoniae in a continuous-infection Model. 2002 Antimicrob. Agents Chemother. pmid:11796350
Strle F and Maraspin V Is azithromycin treatment associated with prolongation of the Q-Tc interval? 2002 Wien. Klin. Wochenschr. pmid:12708094
Dawson CR and Schachter J Should trachoma be treated with antibiotics? 2002 Lancet pmid:11812548
Zubata P et al. A new HPLC method for azithromycin quantitation. 2002 J Pharm Biomed Anal pmid:11814725
Lentino JR and Krasnicka B Association between initial empirical therapy and decreased length of stay among veteran patients hospitalized with community acquired pneumonia. 2002 Int. J. Antimicrob. Agents pmid:11814769
Phillips P et al. Azithromycin prophylaxis for Mycobacterium avium complex during the era of highly active antiretroviral therapy: evaluation of a provincial program. 2002 Clin. Infect. Dis. pmid:11774085
Dzelalija B et al. Randomized trial of azithromycin in the prophylaxis of Mediterranean spotted fever. 2002 Acta Med Croatica pmid:12596623
Silva FM et al. Low efficacy of an ultra-short term, once-daily dose triple therapy with omeprazole, azithromycin, and secnidazole for Helicobacter pylori eradication in peptic ulcer. 2002 Jan-Feb Rev Hosp Clin Fac Med Sao Paulo pmid:12170343
Kadappu KK et al. Azithromycin as treatment for cryptosporidiosis in human immunodeficiency virus disease. 2002 Jul-Sep J Postgrad Med pmid:12432190
Yaqubi GH and Anani GR Prevalence of trachoma in chronic conjunctivitis, Birjand, Islamic Republic of Iran. 2002 Mar-May East. Mediterr. Health J. pmid:15339124
Basilion EV et al. Height as a proxy for weight in determining azithromycin treatment for paediatric trachoma. 2002 Nov-Dec Trans. R. Soc. Trop. Med. Hyg. pmid:12625152
Mileusnic D et al. Pathological case of the month: sudden death in a child as a result of pancreatitis during valproic acid therapy. 2002 Sep-Oct Pediatr Pathol Mol Med pmid:12396903
Seral C et al. Influence of P-glycoprotein inhibitors on accumulation of macrolides in J774 murine macrophages. 2003 Antimicrob. Agents Chemother. pmid:12604540
Roblin PM et al. In vitro activities of rifamycin derivatives ABI-1648 (Rifalazil, KRM-1648), ABI-1657, and ABI-1131 against Chlamydia trachomatis and recent clinical isolates of Chlamydia pneumoniae. 2003 Antimicrob. Agents Chemother. pmid:12604555
Schiedler V et al. Pattern of antibiotic use in a trachoma-endemic region of Nepal: implications for mass azithromycin distribution. 2003 Ophthalmic Epidemiol pmid:12607157
Szpakowski M and Szawłowski A [Azithromycin (Sumamed) administration in empiric treatment of nosocomial pneumonia in upper digestive tract cancer patients]. 2003 Prz. Lek. pmid:14575010
Song Z and Wang C Ultrasensitive assay of azithromycin in medicine and bio-fluids based on its enhanced luminol-H(2)O(2) chemiluminescence reaction using flow injection technique. 2003 Bioorg. Med. Chem. pmid:14642581
Mecaskey JW et al. The possibility of eliminating blinding trachoma. 2003 Lancet Infect Dis pmid:14592604
Lobzin IuV et al. [New achievements in the diagnosis and treatment of disseminated urogenital chlamydiosis]. 2003 Vestn. Akad. Med. Nauk SSSR pmid:14598508
Adachi JA et al. Azithromycin found to be comparable to levofloxacin for the treatment of US travelers with acute diarrhea acquired in Mexico. 2003 Clin. Infect. Dis. pmid:14557959
Sahin-Hodoglugil NN et al. A comparison of cost-effectiveness of three protocols for diagnosis and treatment of gonococcal and chlamydial infections in women in Africa. 2003 Sex Transm Dis pmid:12916139
Laming AC and Currie BJ An evaluation of a SAFE-style trachoma control program in central Australia. 2003 Med. J. Aust. pmid:12921100
Feldman RB et al. Azithromycin monotherapy for patients hospitalized with community-acquired pneumonia: a 31/2-year experience from a veterans affairs hospital. 2003 Arch. Intern. Med. pmid:12885688
Dunne MW et al. Randomized, double-blind study of the clinical efficacy of 3 days of azithromycin compared with co-amoxiclav for the treatment of acute otitis media. 2003 J. Antimicrob. Chemother. pmid:12888586
Farley TA et al. The acceptability and behavioral effects of antibiotic prophylaxis for syphilis prevention. 2003 Sex Transm Dis pmid:14603093
Tyteca D et al. The macrolide antibiotic azithromycin interacts with lipids and affects membrane organization and fluidity: studies on Langmuir-Blodgett monolayers, liposomes and J774 macrophages. 2003 J. Membr. Biol. pmid:12820665
Taylor WR et al. Tolerability of azithromycin as malaria prophylaxis in adults in northeast papua, indonesia. 2003 Antimicrob. Agents Chemother. pmid:12821468
Seral C et al. Quantitative analysis of gentamicin, azithromycin, telithromycin, ciprofloxacin, moxifloxacin, and oritavancin (LY333328) activities against intracellular Staphylococcus aureus in mouse J774 macrophages. 2003 Antimicrob. Agents Chemother. pmid:12821480
Katusic D et al. Azithromycin vs doxycycline in the treatment of inclusion conjunctivitis. 2003 Am. J. Ophthalmol. pmid:12654359
Purkins L et al. No clinically significant effect of erythromycin or azithromycin on the pharmacokinetics of voriconazole in healthy male volunteers. 2003 Br J Clin Pharmacol pmid:14616411
Guchev IA et al. [Prophylaxis of pneumonia occurring outside the hospital in organized groups]. 2003 Voen Med Zh pmid:12722363
Guchev IA et al. [Effect of chemoprophylaxis on pneumonia incidence in organized groups]. 2003 Voen Med Zh pmid:12722514
Maekawa M et al. [Alteration of antibacterial activity of tosufloxacin and various antibacterial agents against Streptococcus pneumoniae]. 2003 Jpn J Antibiot pmid:12723396
Johnson SR et al. Mutations causing in vitro resistance to azithromycin in Neisseria gonorrhoeae. 2003 Int. J. Antimicrob. Agents pmid:12727073
Skerk V et al. Comparative analysis of azithromycin and ciprofloxacin in the treatment of chronic prostatitis caused by Chlamydia trachomatis. 2003 Int. J. Antimicrob. Agents pmid:12727080
Owen WM et al. Efficacy of azithromycin for the treatment of feline chlamydophilosis. 2003 J. Feline Med. Surg. pmid:14623199
Schilling F [Chronic recurrent multifocal osteomyelitis. Opinion exchange concerning the article by T. Seidl et al in Der Orthopäde (2003) 32:535-540]. 2003 Orthopade pmid:14655012
Lin L et al. A retrospective study on clinical features of and treatment methods for 77 severe cases of SARS. 2003 Am. J. Chin. Med. pmid:14992536